Mohammad Reza Daliri

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Hamid Behnam

> Home > Persons > Mohammad Reza Daliri

Publications

2022
[j38]
- view
  authority control:
- export record
  dblp key:
  - journals/tamd/AshtianiBD22
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/tamd/AshtianiBD22
Seyedeh Naghmeh Miri Ashtiani, Hamid Behnam, Mohammad Reza Daliri:
Diagnosis of Multiple Sclerosis Using Graph-Theoretic Measures of Cognitive-Task-Based Functional Connectivity Networks. IEEE Trans. Cogn. Dev. Syst. 14(3): 926-934 (2022)
2019
[j24]
- view
  authority control:
- export record
  dblp key:
  - journals/cbm/AzarmiASBD19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cbm/AzarmiASBD19
Farzad Azarmi, Seyedeh Naghmeh Miri Ashtiani, Ahmad Shalbaf, Hamid Behnam, Mohammad Reza Daliri:
Granger causality analysis in combination with directed network measures for classification of MS patients and healthy controls using task-related fMRI. Comput. Biol. Medicine 115 (2019)
2018
[j22]
- view
  authority control:
- export record
  dblp key:
  - journals/bspc/AshtianiDBHMMF18
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bspc/AshtianiDBHMMF18
Seyedeh Naghmeh Miri Ashtiani, Mohammad Reza Daliri, Hamid Behnam, Gholam-Ali Hossein-Zadeh, Masoud Mehrpour, Mohammad Reza Motamed, Fatemeh Fadaie:
Altered topological properties of brain networks in the early MS patients revealed by cognitive task-related fMRI and graph theory. Biomed. Signal Process. Control. 40: 385-395 (2018)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.